Authors’ Response to Peer Reviews of “Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation”

Meghana Gadgil   ¹ , MD, MPH ;   Rose Pavlakos   ² , PharmD ;   Simona Carini   ¹ , MA ;   Brian Turner   ³ , MBA ;   Ileana Elder   ⁴ , PhD ;   William Hess   ⁴ , BS ;   Lisa Houle   ⁵ , BA ;   Lavonia Huff   ⁴ ;   Elaine Johanson   ⁴ , BS ;   Carole Ramos-Izquierdo   ⁴ , MS, MPM ;   Daphne Liang   ⁴ , PharmD ;   Pamela Ogonowski   ⁴ , MLS (ASCP) ;   Joshua Phipps   ⁶ ;   Tyler Peryea   ⁴ , BA ;   Ida Sim   ^{1, 3} , MD, PhD

¹ Division of General Internal Medicine, University of California, San Francisco, San Francisco, CA, United States

² Division of Cardiology, University of California, San Francisco, San Francisco, CA, United States

³ Clinical and Translational Science Institute, University of California, San Francisco, San Francisco, CA, United States

⁴ Food and Drug Administration, Silver Spring, MD, United States

⁵ Tuvli, LLC, Herndon, VA, United States

⁶ Conceptant, Inc, Falls Church, VA, United States